Page last updated: 2024-11-05

2-cyanophenol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-Cyanophenol, also known as o-cyanophenol, is an organic compound with the formula C7H5NO. It is a colorless solid that is used in the synthesis of other organic compounds. 2-Cyanophenol is a versatile building block for the synthesis of a variety of pharmaceuticals, agrochemicals, and other fine chemicals. It is also a key intermediate in the production of dyes, pigments, and resins. 2-Cyanophenol can be synthesized by the reaction of 2-aminophenol with cyanogen bromide. It can also be prepared by the reaction of o-chlorophenol with sodium cyanide. 2-Cyanophenol is a potentially toxic compound. It can cause skin, eye, and respiratory irritation. It should be handled with care in a well-ventilated area. The compound is studied for its potential use in the development of new pharmaceuticals. For example, it has been shown to have antifungal activity and has been investigated as a potential treatment for cancer. In addition, 2-Cyanophenol is a promising candidate for the development of new materials with improved properties, such as electrical conductivity and optical transparency. Its importance in research lies in its potential applications in various fields. Research on 2-cyanophenol aims to explore its chemical properties, its biological activity, and its potential use in the development of new technologies.'

2-cyanophenol: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11907
CHEMBL ID195342
CHEBI ID194657
SCHEMBL ID5756
MeSH IDM0550814

Synonyms (64)

Synonym
AC-3142
salicylnitrile
o-hydroxybenzonitrile
o-cyanophenol
nsc-53558
2-cyanophenol
benzonitrile, o-hydroxy-
o-hydoxybenzonitrile
nsc53558
salicylonitrile
611-20-1
inchi=1/c7h5no/c8-5-6-3-1-2-4-7(6)9/h1-4,9
benzonitrile, 2-hydroxy-
2-hydroxybenzonitrile
2-hydroxybenzonitrile, 99%
STK067741
2-hydroxy-benzonitrile
CHEMBL195342
AKOS000120269
A21190
dtxcid1021661
cas-611-20-1
NCGC00255417-01
dtxsid3041661 ,
tox21_302110
0r0 ,
benzonitrile, hydroxy-
69481-42-1
nsc 53558
51rsm8k1vz ,
einecs 210-259-3
ec 210-259-3
unii-51rsm8k1vz
FT-0612583
AM20050114
AB01333378-02
hydroxy benzonitrile
cyano-phenol
orthocyanophenol
o-hydroxybenzonitril
2-hydroxylbenzonitrile
cyanophenol
2-hydroxy benzonitrile
2-cyano phenol
hydroxybenzonitrile
2-hydroxyphenyl cyanide
bdbm36298
SCHEMBL5756
2-cyanphenol
Q-200267
STR01814
F0001-1605
mfcd00002145
febuxostat impurity
CS-W013585
NCGC00340789-01
EN300-20326
bunitrolol intermediates
CCG-302494
Q27260915
(r)-2-methylsuccinicacid4-tert-butylester
CHEBI:194657
HY-W012869
Z104477750
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
benzenesAny benzenoid aromatic compound consisting of the benzene skeleton and its substituted derivatives.
nitrileA compound having the structure RC#N; thus a C-substituted derivative of hydrocyanic acid, HC#N. In systematic nomenclature, the suffix nitrile denotes the triply bound #N atom, not the carbon atom attached to it.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (3)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency21.68990.001530.607315,848.9004AID1224848
estrogen nuclear receptor alphaHomo sapiens (human)Potency19.87510.000229.305416,493.5996AID743069; AID743078
aryl hydrocarbon receptorHomo sapiens (human)Potency53.58020.000723.06741,258.9301AID743085; AID743122
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID728438Binding affinity to Enterobacteria phage T4 lysozyme L99A/M102H double mutant expressed in Escherichia coli BL21(DE3) assessed as change in melting temperature at 1 mM at pH 3.05 by circular dichroism analysis2013Journal of medicinal chemistry, Apr-11, Volume: 56, Issue:7
The impact of introducing a histidine into an apolar cavity site on docking and ligand recognition.
AID282833Activity against caspase-mediated apoptosis in mouse L1210 cells at 0.1 mM2005Journal of medicinal chemistry, Nov-17, Volume: 48, Issue:23
Cellular apoptosis and cytotoxicity of phenolic compounds: a quantitative structure-activity relationship study.
AID237685Lipophilicity determined as logarithm of the partition coefficient in the alkane/water system2005Journal of medicinal chemistry, May-05, Volume: 48, Issue:9
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
AID282835Cytotoxicity against mouse L1210 cells2005Journal of medicinal chemistry, Nov-17, Volume: 48, Issue:23
Cellular apoptosis and cytotoxicity of phenolic compounds: a quantitative structure-activity relationship study.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 36.00

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index36.00 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index43.22 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (36.00)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]